$31.08
-0.03-0.10%
At close: Dec 16, 4:00 PM EST
$31.07
-0.01-0.03%
After Hours: 8:08 AM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galapagos (GLPG) stock?
You can purchase shares of Galapagos (NASDAQ:GLPG) through any online brokerage.
Who are Galapagos (GLPG) competitors?
Other companies in Galapagos’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Syndax Pharmaceuticals Inc (NASDAQ:SNDX).
What is the forecast, or price target, for Galapagos (GLPG) stock?
Galapagos has a consensus price target of $41.13.
What is the current price for Galapagos (GLPG)?
The stock price for Galapagos (NASDAQ: GLPG) is $31.07 last updated December 16, 2025 at 8:08 AM EST.
Does Galapagos (GLPG) pay a dividend?
There are no upcoming dividends for Galapagos.
When is Galapagos (NASDAQ:GLPG) reporting earnings?
Galapagos does not have any upcoming earnings scheduled.
Is Galapagos (GLPG) going to split?
There is no upcoming split for Galapagos.
What sector and industry does Galapagos (GLPG) operate in?
Galapagos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
